Home › Companies › Biopharma, Health Care, Medical, Pharmaceutical, Therapeutics › Aerium Therapeutics
Aerium Therapeutics
Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
Aerium Therapeutics operates in biopharma, health care, medical, pharmaceutical, therapeutics based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2021.
The company sits in the biopharma, health care, medical, pharmaceutical, therapeutics segment, where it competes on its core product or service.
Greater Boston Area, East Coast, New England, Northeastern US is where the company is located.
Directory data places it at the Series_A stage.
Its team size is recorded as c_00001_00010 employees.
| Sector | Biopharma, Health Care, Medical, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | series_a |
Website: www.aeriumtx.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account